Bio-Connect

Factor X antibody

Research Use Only
GTX110300
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetF10
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Factor X antibody
  • Delivery Days Customer
    9
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1.05 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2159
  • Target name
    F10
  • Target description
    coagulation factor X
  • Target synonyms
    coagulation factor X; factor X; factor Xa; FX; FXA; prothrombinase; Stuart-Prower factor
  • Host
    Rabbit
  • Isotype
    IgG
  • Scientific Description
    This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. [provided by RefSeq]
  • Reactivity
    Human, Mouse
  • Storage Instruction
    2°C to 8°C,-20°C or -80°C
  • UNSPSC
    12352203

References

  • Anticoagulants inhibit proteolytic clearance of plasma amyloid beta. Yang L et al., 2018 Jan 19, Oncotarget
    Read more
  • A plasma proteolysis pathway comprising blood coagulation proteases. Yang L et al., 2016 Jul 5, Oncotarget
    Read more
  • A hexon-specific PEGylated adenovirus vector utilizing blood coagulation factor X. Matsui H et al., 2012 May, Biomaterials
    Read more